Get started
RKLB dip buying opportunity Many high beta stocks in the space and AI sectors are dumping right now. RKLB sits at an attractive price level after today's sell-off for long-term investing. - 61.80% retracement of a move from April 2025 - Falling wedge pattern that's typically bullish once broken - Ascending trendline that has been tested 3 times now - MFI keeps rising despite bearish price movement Additionally, earnings season is approaching which is likely to change the market sentiment soon.
NASDAQ:RKLBLong
by trader315269
4
Q1 2026 13F: The 10 Biotech Names 20 Funds Actually Bought▪️ Q1 2026 13F — INSTITUTIONAL CONVICTION SNAPSHOT ▪️ 20 specialist biotech funds filed Q1 2026: 73 brand-new positions, 201 positions increased, and — notably — zero complete exits. Nobody is walking away from anything. Capital is being added, not rotated out. ▪️ Filings run on a 45-day delay, so this is a map of where conviction was built during the quarter, not a live tape. The signal is convergence: when independent specialist funds land on the same name in the same window, that is the tell worth trading around. ▪️ Primary read is risk-on and accumulative. New-money convergence is clustering in early-stage oncology and cell therapy; add-money is concentrating in mid/late-stage names that already have institutional ownership — funds doubling down on work already done. ▪️ TOP 10 CONVICTION IDEAS ▪️ 1 — DFTX (Definium Therapeutics) · 7 funds · new · $335M Highest convergence on the entire filing. Seven specialists initiating cold in one quarter is the rarest signal in this dataset. Driehaus, Avoro, Deep Track +4. ▪️ 2 — INSM (Insmed) · 4 funds adding · $2.1B Largest capital block on the sheet. Baker Bros, RTW and Eventide adding to a $2B position is scale conviction, not a starter bet. ▪️ 3 — PRAX (Praxis Precision Medicines) · 5 funds adding · $1.9B Five funds adding into a near-$2B book. Best blend of breadth and size — the strongest conviction-plus-scale name here. ▪️ 4 — DMRA (Damora Therapeutics) · 5 funds · new · $282M Second-highest new-position convergence. Avoro, RA Capital, Commodore +2 all stepping in fresh at meaningful size. ▪️ 5 — RVMD (Revolution Medicines) · 4 funds adding · $1.2B Billion-dollar position getting bigger. Baker Bros, Avoro and Perceptive adding together is a heavyweight cluster. ▪️ 6 — CNTA (Centessa Pharmaceuticals) · 5 funds adding · $668M Five-fund add at mid-cap size. EcoR1, Perceptive and Deep Track leaning in on an existing book. ▪️ 7 — PCVX (Vaxcyte) · 4 funds adding · $1.0B Billion-dollar position, four funds adding. Institutional core holding being reinforced, not trimmed. ▪️ 8 — TNGX (Tango Therapeutics) · 5 funds adding · $469M Broadest add outside the mega-positions. RTW, Deerfield and Deep Track stacking on the same name. ▪️ 9 — IRTC (iRhythm Holdings) · 4 funds · new · $330M Largest new-position dollar value relative to fund count — the medtech outlier in an otherwise therapeutics-heavy list. High conviction per fund. ▪️ 10 — AKTS (Aktis Oncology) · 5 funds · new · $169M Five-fund cold start. EcoR1, RTW and RA Capital converging on radiopharma exposure at the same time. ▪️ WHAT DIDN'T MAKE THE CUT CMPS, CGON, XENE, IRON, CRVS, IPSC, STRO, AGMB, ZURA, EIKN — real activity, but either thin fund counts, sub-$100M size, or both. Not enough weight behind them to trade off. Skipped. ▪️ THE STRUCTURAL TELL Zero exits across 20 funds is the number to sit with. Specialists are not de-risking. Every dollar of movement this quarter was directional accumulation — new convergence at the small-cap end (DFTX, DMRA, AKTS), reinforcement at the large end (INSM, PRAX, RVMD, PCVX). That is a barbell, and it usually precedes a catalyst-heavy stretch. ▪️ ProjectSyndicate Levels Desk — Overview of key S/R zones for NQ, ES, GC & JPN225 traders every week. Subscribe to stay up to date with the latest levels.
NASDAQ:IRTCLong
by ProjectSyndicate
1
38.2% Fibonacci Retest Buying Opportunity?The stock has shown a strong bounce after finding support near the 23.6% Fibonacci level, with previous support zone. Instead of buying after such a big green candle, Wait for a pullback toward $95.30 (FIB level 61.80). If buyers step in again and the price starts moving higher from there, it could offer a better entry with less risk. stop loss would be $88.80 just below the FIB level 23.60, if a daily close below this level would make the bullish setup no longer valid. TP1: $99.40 TP2: $103.50 TP3: $108.60 TP4: $116.90 Wait for the price to come to a good support area and let the market confirm the direction before entering. Disclaimer: The information provided is for educational and informational purposes only. It does not constitute financial or investment advice. Trading and investing in stocks involves risk, including the possible loss of capital. Any decisions to buy, sell, or hold securities are the sole responsibility of the reader. Past performance is not indicative of future results. Always do your own research and, if necessary, consult with a licensed financial advisor before making investment decisions.
NYSE:ABT
by AlphaFox-Traders
Interesting Pattern showing up on the $GME 2hr chartSomeone with more brainpower and better indicators can probably give us more insight but I wanted to put this out there to see if anyone else has picked up on this. The pattern: On the 2hr chart, (almost) every time we cross the 200 day MA, the price runs considerably. Between these crosses and big runs, there are some "bumps" over the 200 day followed by strong sell pressure which leads to the local bottom followed by the powerful run. We appear to be completing the latest "bumps" in the cycle and about to see some strong sell pressure back under the 200 day into next week. If the pattern plays out, we should see a dip below $21 over the next week followed by a strong reversal that plays out over the following 3-4 weeks. Also - Note the time between runs (blue boxes) and "bumps (yellow boxes). The push under the 200 day out of the yellow box is usually violent, as is the re-break of the 200 day on the way back up when it finally reaches it. Please comment any thoughts/ideas and let me know if I've eaten too many crayons.
NYSE:GME
by eblanchet
1
Micron Technology Inc, (MU): Anticipate A Bearish PullbackMicron Technology (MU) stock is experiencing a slight pullback, recently trading near $979 following a surge driven by a massive $250 billion U.S. manufacturing and research investment commitment. The stock faces mild pressure from profit taking and the historic Nasdaq debut of its rival, SK Hynix. Technical Outlook: Stock recently broke below the trend support line, at $1,035, after a few months of bullish surge. Price is currently making a retest of breakout, in respect of the structure. We are anticipating a short term sell at this point. Key Outline: A confirmed bearish retracement, activates a sell position down to $843, as next possible support. Thanks for reading.
NASDAQ:MUShort
by Blaisefxacademy
7
Can Tesla Finally Break $433 or Will Another Lower High Form?Tesla has delivered strong headlines recently, but the chart suggests the real test is only beginning. After rebounding from around $369 to nearly $433, price failed to reclaim the previous lower highs and is now consolidating near $408, a level where multiple technical factors are starting to overlap. 📊 From a technical perspective, TSLA is trading inside a decision zone rather than a confirmed trend. The $404 to $412 area aligns closely with the 38.2% Fibonacci retracement of the latest impulse, making it an important pivot. Meanwhile, the $390 to $396 demand zone coincides with the 61.8% retracement, creating a stronger support region if sellers push price lower. ⚠️ The bearish structure is still intact for now. Although buyers produced an impressive recovery from the June low, the sequence of lower highs remains unbroken. The recent rejection near $433 leaves that level as the first major confirmation point. A daily close above it would signal a meaningful Change of Character (CHoCH), while reclaiming $453.40 would confirm a broader bullish Break of Structure. 🎯 I'm watching two scenarios. If price revisits the $390 to $396 demand zone and shows bullish confirmation, that could provide a higher-probability long setup targeting $412, $428, and eventually $443. On the other hand, if TSLA rallies back into the $425 to $433 supply zone and loses momentum again, it could offer a bearish opportunity with downside targets around $408, $395, and $380. The chart also includes clearly marked support and resistance levels, supply and demand zones, liquidity areas, Fibonacci confluence, bullish and bearish scenarios, invalidation levels, and target zones. Until either $433 breaks to the upside or $390 fails to the downside, I see TSLA trading in a high-interest decision area where confirmation matters more than anticipation. What do you think? Is Tesla building a base for the next breakout, or is the rejection below $433 another lower high before the next leg down?
NASDAQ:TSLA
by zenthena00
2
ABEV - Bearish Trend Faces a Major Test!ABEV (Ambev S.A.) is one of the largest beverage companies in Latin America, producing and distributing well-known beer, soft drink, and beverage brands across the region. The stock has attracted long-term investors due to its strong market position and defensive business model. From a technical perspective, ABEV remains overall bearish, continuing to trade inside the red descending channel that has guided price action over the longer term. Over the past few years, price has been consolidating inside the orange trading range and has now reached an important technical area where the upper boundary of the descending channel aligns with the range resistance. ⭕This confluence creates an attractive area to monitor for sell setups on lower timeframes, particularly if price shows signs of rejection from the current resistance. ⭕However, if buyers manage to break above both the range resistance and the descending channel, it could provide the first strong indication that the long-term bearish trend is losing control and that a broader bullish reversal may be beginning. The reaction around this technical zone may determine whether sellers can maintain control of the broader trend, or if buyers are preparing to shift the long-term market structure. ⚠️ Disclaimer: This analysis reflects my personal market view and is not financial advice. Rayan Nasser #ABEV #Stocks #Investing #TechnicalAnalysis #PriceAction #MarketStructure #TrendAnalysis
NYSE:ABEVShort
by Rayannsr
$IBM — Long-term support retestThe current price action of NYSE:IBM is unfolding as expected, with long-term support providing a lift upwards. The next resistance level is anticipated to be just a few percent higher. A key factor to watch will be how the stock performs once it enters the gap area, potentially acting as a magnet drawing prices upwards. This movement, in conjunction with short-term averages, could result in a strong upward trajectory. The reasoning behind this analysis is based on the premise that long-term support levels and gaps can significantly influence future price movements. It's crucial to monitor how NYSE:IBM interacts with these technical levels for confirmation or invalidation of this idea. Not financial advice.
NYSE:IBMLong
by Stockguruvip
Sndk Nehemiah 6:15 — "So the wall was finished in the twenty and fifth day of the month Elul, in fifty and two days. And it came to pass, that when all our enemies heard thereof, and all the heathen that were about us saw these things, they were much cast down in their own eyes: for they perceived that this work was wrought of our God." SNDK — the wall is being rebuilt. Stone by stone. Day by day. The enemies saw it and trembled. They could not stop what was wrought. 1,840 is the finished wall. The completion. All shall see. All shall know.
NASDAQ:SNDKLong
by themanfromthefuture
LONG - Post-Earnings Breakout + Record Leasing&Raised Guidance📍 ENTRY: $148.00 🛑 **STOP LOSS:** $135.00 (Risk: $13.00) 🎯 **TAKE PROFIT:** $175.00 (Reward: $27.00) 📊 R:R RATIO: ~1:2.08 🔍 TECHNICAL ANALYSIS (The Setup): PLD is trading at ~$143** after reporting earnings today (July 16). My entry at **$148 is positioned above the current price, anticipating a breakout toward the 52-week high of $150.18 and beyond. The stock has been consolidating in a well-defined range between support at $131** and resistance at **$150 over recent weeks . The **stop loss at $135** is placed safely **below the key support zone** ($131–$135) and gives the trade room to breathe while protecting against a false breakout. Target at $175**: This sits well above the current average analyst price target of **$153.43 and approaches the highest targets from top analysts like BTIG at $170 . 52-week range: $103.41 – $150.18 — a clean break above $150 would open the door to new highs. 📊 FUNDAMENTAL ANALYSIS (The Catalyst – Just Released!): Prologis reported Q2 2026 earnings this morning (July 16) and the numbers were exceptional: ✅ EPS of $1.13** crushed the $0.75 consensus estimate by +$0.38** . ✅ **Revenue of $2.43B beat the $2.16B estimate by **+12.5%** . ✅ **Core FFO of $1.63/share (+11.6% YoY), well above the ~$1.53 consensus . ✅ **Net earnings nearly doubled** to $1.06B vs $570M in Q2 2025 . ✅ Record leasing: Signed over 67 million square feet — the highest in company history . ✅ Occupancy rose to 95.5% from 95.3% in Q1 . ✅ Net effective rent growth rebounded to 36.9% (vs 31.9% in Q1) — signaling renewed pricing power . Guidance Raised for the Second Time This Year: FY2026 EPS guidance lifted to $4.40–$4.55 (from $3.80–$4.05) . Core FFO guidance raised to $6.22–$6.30 (from $6.07–$6.23) . Key Growth Driver – Data Center Expansion: Data center power pipeline expanded to 5.8 GW . Nearly $802M of Q2 development starts tied to data centers . CEO Daniel Letter stated customer demand is broadening across logistics, digital infrastructure and energy . Analyst Reaction (Today): Firm Rating Price Target BMO Capital Buy $158 (reaffirmed) Barclays Overweight **$156** (raised from $139) Wells Fargo Buy $167 BTIG Buy $170 Consensus (24 analysts) Buy $153.43 🎯 TRADE STRATEGY: Entry at $148:** Entering after the post-earnings momentum, anticipating a clean break above the **52-week high of $150.18. **SL at $135:** Placed safely below the key support zone ($131–$135) and the 200-day moving average. If price loses this level, the bullish breakout thesis is invalidated. **TP at $175:** Approaching the highest analyst targets ($170 from BTIG) — capturing the full upside of the strong fundamental setup. ⚠️ RISK MANAGEMENT: Earnings volatility: PLD is up ~3.7% today . A "sell-the-news" reaction could still occur if the market chooses to take profits. Valuation concerns: GuruFocus GF Value™ for PLD is $132.16, suggesting the stock is ~8.5% overvalued at current levels . Operating costs: G&A expenses surged 21.3% YoY, raising some margin questions . Interest rate environment: As a REIT, PLD is sensitive to rising rates, though its debt-to-adjusted EBITDA ratio of 4.7x and weighted average interest rate of 3.3% provide a cushion . 💬 What are your thoughts? Is anyone else watching this post-earnings breakout, or do you expect a pullback before the next leg up toward $175? ⚠️ DISCLAIMER: This is NOT financial or investment advice. This post reflects my personal opinion and analysis based on publicly available information. Trading and investing involve substantial risk, including the potential loss of your entire capital. Past performance does not guarantee future results. Always do your own research (DYOR) and consult with a licensed financial advisor before making any trading decisions. I am not responsible for any losses incurred. #PLD #Prologis #Earnings #REIT #Breakout #DataCenter #TradingSetup #TechnicalAnalysis #Stocks
NYSE:PLDLong
by shortermtrader